Association between interleukin-10 polymorphisms and alzheimer's disease: A systematic review and meta-analysis

Journal of Alzheimer's Disease

Volumn 29, Issue 4, 2012, Pages 751-759

  Di Bona, Danilo ^a,b   Rizzo, Claudia ^a   Bonaventura, Giuseppe ^a   Candore, Giuseppina ^a   Caruso, Calogero ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b CNR Consiglio Nazionale delle Ricerche   (Italy)

Author keywords

Alzheimer's disease; IL 10; meta analysis; polymorphisms

Indexed keywords

INTERLEUKIN 10;

ALZHEIMER DISEASE; ARTICLE; CASE CONTROL STUDY; DATA EXTRACTION; DISEASE COURSE; DISEASE PREDISPOSITION; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; META ANALYSIS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMATIC REVIEW;

EID: 84860115835     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2012-111838     Document Type: Article

References (36)

1. Akiyama H, Barger S, Barnum S, Bradt B, Bauer J, Cole GM, Cooper NR, Eikelenboom P, Emmerling M, Fiebich BL, Finch CE, Frautschy S, Griffin WS, Hampel H, Hull M, Landreth G, Lue L, Mrak R, Mackenzie IR, Mc Geer PL, O'Banion MK, Pachter J, Pasinetti G, Plata-Salaman C, Rogers J, Rydel R, Shen Y, Streit W, Strohmeyer R, Tooyoma I, Van Muiswinkel FL, Veerhuis R, Walker D, Webster S, Wegrzyniak B, Wenk G, Wyss-Coray T (2000) Inflammation and Alzheimer's disease. Neurobiol Aging 21, 383-421. (Pubitemid 30349107)
2. Vasto S, Candore G, List̀i F, Balistreri CR, Colonna-Romano G, Malavolta M, Lio D, Nuzzo D, Mocchegiani E, Di Bona D, Caruso C (2008) Inflammation, genes and zincin Alzheimer's disease. Brain Res Rev 58, 96-105.
3. Mrak RE, Griffin WS (2005) Glia and their cytokines in progression of neurodegeneration. Neurobiol Aging 26, 349-354. (Pubitemid 40082718)
4. Mrak RE, Griffin WS (2005) Potential inflammatory biomark-ers in Alzheimer's disease. J Alzheimers Dis 8, 369-375.
5. DiBona D, Plaia A, Vasto S, Cavallone L, Lescai F, Franceschi C, Licastro F, Colonna-Romano G, Lio D, Candore G, Caruso C (2008) Association between the interleukin-1beta polymorphisms and Alzheimer's disease: A systematic review and meta-analysis. Brain Res Rev 59, 155-163.
6. Di Bona D, Candore G, Franceschi C, Licastro F, Colonna-Romano G, Cammà C, Lio D, Caruso C (2009) Systematic review by meta-analyses on the possible role of TNF-alpha polymorphisms in association with Alzheimer's disease. Brain Res Rev 61, 60-68.
7. Zhang Y, Zhang J, Tian C, Xiao Y, Li X, He C, Huang J, Fan H (2011) The-1082G/A polymorphism in IL-10 gene is associated with risk of Alzheimer's disease: A meta-analysis. J Neurol Sci 303, 133-138.
8. Mosser DM, Zhang X (2008) Interleukin-10: New perspectives on an old cytokine. Immunol Rev 226, 205-218.
9. Edwards-Smith CJ, Jonsson JR, Purdie DM, Bansal A, Shorthouse C, Powell EE (1999) Interleukin-10 promoter polymorphism predicts initial response of chronic hepatitis C to interferon alfa. Hepatology 30, 526-530. (Pubitemid 29357520)
10. Lio D, Candore G, Crivello A, Scola L, Colonna-Romano G, Cavallone L, Hoffmann E, Caruso M, Licastro F, Caldar-era CM, Branzi A, Franceschi C, Caruso C (2004) Opposite effects of interleukin 10 common gene polymorphisms in cardiovascular diseases and in successful ageing: Genetic background of male centenarians is protective against coronary heart disease. J Med Genet 41, 790-794. (Pubitemid 39389298)
11. Lio D, Licastro F, Scola L, Chiappelli M, Grimaldi LM, Crivello A, Colonna-Romano G, Candore G, Franceschi C, Caruso C (2003) Interleukin-10 promoter polymorphism in sporadic Alzheimer's disease. Genes Immun 4, 234-238. (Pubitemid 38967602)
12. Arosio B, Trabattoni D, Galimberti L, Bucciarelli P, Fasano F, Calabresi C, Cazzullo CL, Vergani C, Annoni G, Clerici M (2004) Interleukin-10 and interleukin-6 gene polymorphisms as risk factors for Alzheimer's disease. Neurobiol Aging 25, 1009-1015. (Pubitemid 38798062)
13. Depboylu C, Du Y, Müller U, Kurz A, Zimmer R, Riemenschneider M, Gasser T, Oertel WH, Klockgether T, Dodel RC (2003) Lack of association of interleukin-10 promoter region polymorphisms with Alzheimer's disease. Neurosci Lett 15, 342-344.
14. Infante J, Sanz C, Fernández-Luna JL, Llorca J, Berciano J, Combarros O (2004) Gene-gene interaction between interleukin-6 and interleukin-10 reduces AD risk. Neurology 63, 1135-1136. (Pubitemid 39287939)
15. Scassellati C, Zanardini R, Squitti R, Bocchio-Chiavetto L, Bonvicini C, Binetti G, Zanetti O, Cassetta E, Gennarelli M (2004) Promoter haplotypes of interleukin-10 gene and sporadic Alzheimer's disease. Neurosci Lett 356, 119-122. (Pubitemid 38121483)
16. Nishimura M, Sakamoto T, Kaji R, Kawakami H (2004) Influence of polymorphisms in the genes for cytokines and glutathione S-transferase omega on sporadic Alzheimer's disease. Neurosci Lett 368, 140-143. (Pubitemid 39194859)
17. Ma SL, Tang NL, Lam LC, Chiu HF (2005) The association between promoter polymorphism of the interleukin-10 gene and Alzheimer's disease. Neurobiol Aging 26, 1005-1010. (Pubitemid 40312663)
18. Ramos EM, Lin MT, Larson EB, Maezawa I, Tseng LH, Edwards KL, Schellenberg GD, Hansen JA, Kukull WA, Jin LW (2006) Tumor necrosis factor alpha and interleukin 10 promoter region polymorphisms and risk of late-onset Alzheimer disease. Arch Neurol 63, 1165-1169. (Pubitemid 44232326)
19. Culpan D, Prince JA, Matthews S, Palmer L, Hughes A, Love S, Kehoe PG, Wilcock GK (2006) Neither sequence variation in the IL-10 gene promoter nor presence of IL-10 protein in the cerebral cortex is associated with Alzheimer's disease. Neurosci Lett 408, 141-145. (Pubitemid 44515135)
20. Bagnoli S, Cellini E, Tedde A, Nacmias B, Piacentini S, Bessi V, Bracco L, Sorbi S (2007) Association of IL10 promoter polymorphism in Italian Alzheimer's disease. Neurosci Lett 418, 262-265. (Pubitemid 46670562)
21. Giedraitis V, Kilander L, Degerman-Gunnarsson M, Sundelöf J, Axelsson T, Syvänen AC, Lannfelt L, Glaser A (2009) Genetic analysis of Alzheimer's disease in the uppsala longitudinal study of adult men. Dement Geriatr Cogn Disord 27, 59-68.
22. Vural P, Deǧirmencioǧlu S, Parildar-Karpuzoǧlu H, Doǧru-Abbasoǧlu S, Hanagasi HA, Karadaǧ B, Gürvit H, Emre M, Uysal M (2009) The combinations of TNFalpha-308 and IL-6-174 or IL-10-1082 genes polymorphisms suggest an association with susceptibility to sporadic late-onset Alzheimer's disease. Acta Neurol Scand 120, 396-401.
23. Cousin E, Macé S, Rocher C, Dib C, Muzard G, Hannequin D, Pradier L, Deleuze JF, Génin E, Brice A, Campion D (2011) No replication of genetic association between candidate polymorphisms and Alzheimer's disease. Neurobiol Aging 32, 1443-1451.
24. Shawkatová I, Javor J, Párnická Z, Vrazda L, Novák M, Buc M (2010) No association between cytokine gene polymorphism and risk of Alzheimer's disease in Slovaks. Acta Neurobiol Exp (Wars) 70, 303-307.
25. Ribizzi G, Fiordoro S, Barocci S, Ferrari E, Megna M (2010) Cytokine polymorphisms and Alzheimer disease: Possible associations. Neurol Sci 31, 321-325.
26. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of department of health and human services task force on Alzheimer's disease. Neurology 34, 939-944. (Pubitemid 14076461)
27. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials Controlled. Clin Trials 7, 177-188.
28. Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21, 1539-1558. (Pubitemid 34746062)
29. Dupont WD, Plummer WD Jr (1990) Power and sample size calculations: A review and a computer program. Control Clin Trials 11, 116-128. (Pubitemid 20136185)
30. Bertram L, McQueen MB, Mullin K, Blacker D, Tanzi RE (2007) Systematic meta-analyses of Alzheimer disease genetic association studies: The AlzGene database. Nat Genet 39, 17-23. (Pubitemid 46026496)
31. Combarros O, Sánchez-Juan P, Riancho JA, Mateo I, Rodrìguez-Rodrìguez E, Infante J, Garcìa-Gorostiaga I, Vázquez-Higuera JL, Berciano J (2008) Aromatase and interleukin-10 genetic variants interactively modulate Alzheimer's disease risk. J Neural Transm 115, 863-867.
32. Candore G, Bulati M, Caruso C, Castiglia L, Colonna-Romano G, Di Bona D, Duro G, Lio D, Matranga D, Pellicanò M, Rizzo C, Scapagnini G, Vasto S (2010) Inflammation, cytokines, immune response, apolipoprotein E, cholesterol, and oxidative stress in Alzheimer disease: Therapeutic implications. Rejuvenation Res 13, 301-313.
33. Di Bona D, Scapagnini G, Candore G, Castiglia L, Colonna-Romano G, Duro G, Nuzzo D, Iemolo F, Lio D, Pellicanò M, Scafidi V, Caruso C, Vasto S (2010) Immune-inflammatory responses and oxidative stress in Alzheimer's disease: Therapeutic implications. Curr Pharm Des 16, 684-691.
34. Di Bona D, Vasto S, Capurso C, Christiansen L, Deiana L, Franceschi C, Hurme M, Mocchegiani E, Rea M, Lio D, Candore G, Caruso C (2009) Effect of interleukin-6 polymorphisms on human longevity: A systematic review and meta-analysis. Ageing Res Rev 8, 36-42.
35. Licastro F, Chiappelli M, Caldarera CM, Porcellini E, Carbone I, Caruso C, Lio D, Corder EH (2011) Sharing patho-genetic mechanisms between acute myocardial infarction and Alzheimer's diseaseasshownbypartially overlapping ofgene variant profiles. J Alzheimers Dis 23, 421-431.
36. Vasto S, Candore G, Balistreri CR, Caruso M, Colonna-Romano G, Grimaldi MP, Listi F, Nuzzo D, Lio D, Caruso C (2007) Inflammatory networks in ageing, age-relateddiseases and longevity. Mech Ageing Dev 128, 83-91. (Pubitemid 46073064)